(1) Nataro JP, Kaper JB. Diarrheagenic Escherichia coli.
Clin Microbiol Rev 1998; 11(1):142-201.
(2) Kaper JB, Karmali MA. The continuing evolution of a bacterial pathogen.
Proc Natl Acad Sci U S A 2008; 105(12):4535-6.
(3) Escherich T. Die Darmbakterien des Neugeborenen und Sauglingen.
Fortschr Med 1885; 3:515-28.
(4) Edwards PR, Ewing WH. Identification of Enterobacteriaceae. 3rd ed. Burgess Publishing Co., Minneapolis, Minn., 1972: 362.
(5) Lior H. Classification of Escherichia coli. In: C.L.Gyles, ed. Escherichia coli in domestic animals and humans. CAB International Wallingford, UK, 1996:31-72.
(6) Scheutz F, Cheasty T, Woodward D, Smith HR. Designation of O174 and O175 to temporary O groups OX3 and OX7, and six new E. coli O groups that include
Verocytotoxin-producing E. coli (VTEC): O176, O177, O178, O179, O180 and O181.
APMIS 2004; 112(9):569-84.
(7) Drasar BS and Hill MJ. Human intestinal flora.London UK: Academic Press, LTD, 1974:36-43.
(8) Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli.
Infect Immun 1977; 18(3):775-9.
(9) O'Brien AO, Lively TA, Chen ME, Rothman SW, Formal SB. Escherichia coli
O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet 1983; 1:702.
(10) Levine MM, Xu JG, Kaper JB, et al. A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis 1987; 156(1):175-82.
(11) Orth D, Wurzner R. What makes an enterohemorrhagic Escherichia coli?
Clin Infect Dis 2006; 43(9):1168-9.
(12) Robert Koch-Institut. RKI-Ratgeber Infektionskrankheiten - Merkblätter für Ärzte.
Epidemiologisches Bulletin 2008;(2):11-5.
(13) Diarrhea caused by Eschericia coli. I Enterohemorrhagic Strains. In: Heyman DL, ed.
Control of Communicable Disease Manual. 19 ed. Washington DC: American Public Health Association, 2008:181-5.
(14) Gould LH, Demma L, Jones TF, et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 2009; 49(10):1480-5.
(15) Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002; 186(4):493-500.
(16) Werber D, Fruth A, Heissenhuber A, et al. Shiga toxin-producing Escherichia coli O157 more frequently cause bloody diarrhea than do non-O157 strains.
J Infect Dis 2004; 189(7):1335-6.
(17) Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365(9464):1073-86.
(18) Sonntag AK, Prager R, Bielaszewska M, et al. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany.
J Clin Microbiol 2004; 42(3):954-62.
(19) Gould LH, Bopp C, Strockbine N, et al. Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories.
MMWR Recomm Rep 2009; 58(RR-12):1-14.
(20) Ammon A. Surveillance of enterohaemorrhagic E. coli (EHEC) infections and haemolytic uraemic syndrome (HUS) in Europe. Euro Surveill 1997; 2(12):91-6.
(21) Fruth A, Richter H TM. Zur Verbesserung der gegenwärtigen Diagnostik von enterohämorrhagischen Escherichia coli (EHEC).
Bundesgesundheitsblatt 2000; 43: 310-7.
(22) Werber D, Frank C, Wadl M, Karch H, Fruth A, Stark K. Looking for tips to find icebergs--surveillance of haemolytic uraemic syndrome to detect outbreaks of Shiga toxin-producing E. coli infection. Euro Surveill 2008; 13(9).
(23) Friedrich AW, Borell J, Bielaszewska M, Fruth A, Tschape H, Karch H. Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease. J Clin Microbiol 2003; 41(6):2448-53.
(24) Werber D, Fruth A, Frank C, Altmann D, Stark K. Surveillance von
STEC-Erkrankungen in Deutschland 2001-2009: Time for a change. III EHEC-Workshop 2010; Wildbad-Kreuth: 16.
(25) Anonym. Richtlinie 2003/99/EG des Europäischen Parlaments und des Rates vom 17. November 2003 zur Überwachung von Zoonosen und Zoonoseerregern . Amtsblatt L325 2003;31.
(26) Armstrong GL, Hollingsworth J, Morris JG, Jr. Emerging foodborne pathogens:
Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev 1996; 18(1):29-51.
(27) Miko A, Pries K, Haby S, et al. Assessment of Shiga toxin-producing Escherichia coli isolates from wildlife meat as potential pathogens for humans.
Appl Environ Microbiol 2009; 75(20):6462-70.
(28) Asakura H, Makino S, Shirahata T, et al. Detection and genetical characterization of Shiga toxin-producing Escherichia coli from wild deer.
Microbiol Immunol 1998; 42(12):815-22.
(29) Sanchez S, Garcia-Sanchez A, Martinez R, et al. Detection and characterisation of Shiga toxin-producing Escherichia coli other than Escherichia coli O157:H7 in wild ruminants. Vet J 2009; 180(3):384-8.
(30) Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13:60-98.
(31) Naylor SW, Low JC, Besser TE, et al. Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. Infect Immun 2003; 71(3):1505-12.
(32) Smith DG, Naylor SW, Gally DL. Consequences of EHEC colonisation in humans and cattle. Int J Med Microbiol 2002; 292(3-4):169-83.
(33) Cernicchiaro N, Pearl DL, McEwen SA, Lejeune JT. Assessment of Diagnostic Tools for Identifying Cattle Shedding and Super-Shedding Escherichia coli O157:H7 in a Longitudinal Study of Naturally Infected Feedlot Steers in Ohio.
Foodborne Pathog Dis 2011; 8(2):239-48.
(34) Faith NG, Shere JA, Brosch R, et al. Prevalence and clonal nature of Escherichia coli O157:H7 on dairy farms in Wisconsin. Appl Environ Microbiol 1996; 62(5):1519-25.
(35) Sanderson MW, Besser TE, Gay JM, Gay CC, Hancock DD. Fecal Escherichia coli O157:H7 shedding patterns of orally inoculated calves.
Vet Microbiol 1999; 69(3):199-205.
(36) Paiba GA, Wilesmith JW, Evans SJ, et al. Prevalence of faecal excretion of verocytotoxigenic Escherichia coli O157 in cattle in England and Wales.
Vet Rec 2003; 153(12):347-53.
(37) Busch U, Hormansdorfer S, Schranner S, Huber I, Bogner KH, Sing A.
Enterohemorrhagic Escherichia coll excretion by child and her cat.
Emerg Infect Dis 2007; 13(2):348-9.
(38) Urdahl AM, Beutin L, Skjerve E, Wasteson Y. Serotypes and virulence factors of Shiga toxin-producing Escherichia coli isolated from healthy Norwegian sheep.
J Appl Microbiol 2002; 93(6):1026-33.
(39) Rey J, Blanco JE, Blanco M, et al. Serotypes, phage types and virulence genes of shiga-producing Escherichia coli isolated from sheep in Spain.
Vet Microbiol 2003; 94(1):47-56.
(40) Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308(12):681-5.
(41) Karch H, Russmann H, Schmidt H, Schwarzkopf A, Heesemann J. Long-term
shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. J Clin Microbiol 1995; 33(6):1602-5.
(42) Shah S, Hoffman R, Shillam P, Wilson B. Prolonged fecal shedding of Escherichia coli O157:H7 during an outbreak at a day care center.
Clin Infect Dis 1996; 23(4):835-6.
(43) Swerdlow DL, Griffin PM. Duration of faecal shedding of Escherichia coli O157:H7 among children in day-care centres. Lancet 1997; 349(9054):745-6.
(44) Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002.
Emerg Infect Dis 2005; 11(4):603-9.
(45) Rottman M, Gaillard JL. [New foodborne infections]. Rev Prat 2003; 53(10):1055-62.
(46) Two multistate outbreaks of Shiga toxin--producing Escherichia coli infections linked to beef from a single slaughter facility - United States, 2008.
MMWR Morb Mortal Wkly Rep 2010; 59(18):557-60.
(47) Ahn CK, Klein E, Tarr PI. Isolation of patients acutely infected with Escherichia coli O157:H7: low-tech, highly effective prevention of hemolytic uremic syndrome.
Clin Infect Dis 2008; 46(8):1197-9.
(48) Keene WE, Hedberg K, Herriott DE, et al. A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk.
J Infect Dis 1997; 176(3):815-8.
(49) Honish L, Predy G, Hislop N, et al. An outbreak of E. coli O157:H7 hemorrhagic colitis associated with unpasteurized gouda cheese.
Can J Public Health 2005; 96(3):182-4.
(50) De Schrijver K, Buvens G, Possse B, et al. Outbreak of veroytotoxin-producing E.coli O145 and O26 infections associated with the consumption of ice cream produced at a farm, Belgium, 2007. Euro Surveill 200813(7):1-7.
(51) Matsell DG, White CT. An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic. Kidney Int Suppl 2009;(112):S35-S37.
(52) Soderstrom A, Osterberg P, Lindqvist A, et al. A large Escherichia coli O157 outbreak in Sweden associated with locally produced lettuce.
Foodborne Pathog Dis 2008; 5(3):339-49.
(53) Ackers ML, Mahon BE, Leahy E, et al. An outbreak of Escherichia coli O157:H7 infections associated with leaf lettuce consumption.
J Infect Dis 1998; 177(6):1588-93.
(54) Cody SH, Glynn MK, Farrar JA, et al. An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice.
Ann Intern Med 1999; 130(3):202-9.
(55) Wendel AM, Johnson DH, Sharapov U, et al. Multistate outbreak of Escherichia coli O157:H7 infection associated with consumption of packaged spinach, August-September 2006: the Wisconsin investigation. Clin Infect Dis 2009; 48(8):1079-86.
(56) Michino H, Araki K, Minami S, et al. Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol 1999; 150(8):787-96.
(57) Lynch MF, Tauxe RV, Hedberg CW. The growing burden of foodborne outbreaks due to contaminated fresh produce: risks and opportunities.
Epidemiol Infect 2009; 137(3):307-15.
(58) Crump JA, Sulka AC, Langer AJ, et al. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. N Engl J Med 2002; 347(8):555-60.
(59) Payne CJ, Petrovic M, Roberts RJ, et al. Vero cytotoxin-producing Escherichia coli O157 gastroenteritis in farm visitors, North Wales.
Emerg Infect Dis 2003; 9(5):526-30.
(60) Outbreaks of Escherichia coli O157:H7 infections among children associated with farm visits--Pennsylvania and Washington, 2000.
MMWR Morb Mortal Wkly Rep 2001; 50(15):293-7.
(61) Pritchard GC, Willshaw GA, Bailey JR, Carson T, Cheasty T. Verocytotoxin-producing Escherichia coli O157 on a farm open to the public: outbreak investigation and
longitudinal bacteriological study. Vet Rec 2000; 147(10):259-64.
(62) Crump JA, Braden CR, Dey ME, et al. Outbreaks of Escherichia coli O157 infections at multiple county agricultural fairs: a hazard of mixing cattle, concession stands and children. Epidemiol Infect 2003; 131(3):1055-62.
(63) Grif K, Orth D, Lederer I, et al. Importance of environmental transmission in cases of EHEC O157 causing hemolytic uremic syndrome.
Eur J Clin Microbiol Infect Dis 2005; 24(4):268-71.
(64) Bruce MG, Curtis MB, Payne MM, et al. Lake-associated outbreak of Escherichia coli O157:H7 in Clark County, Washington, August 1999.
Arch Pediatr Adolesc Med 2003; 157(10):1016-21.
(65) Verma A, Bolton FJ, Fiefield D, et al. An outbreak of E. coli O157 associated with a swimming pool: an unusual vehicle of transmission.
Epidemiol Infect 2007; 135(6):989-92.
(66) Rivas M, Sosa-Estani S, Rangel J, et al. Risk factors for sporadic Shiga toxin-producing Escherichia coli infections in children, Argentina.
Emerg Infect Dis 2008; 14(5):763-71.
(67) O'Brien SJ, Adak GK, Gilham C. Contact with farming environment as a major risk factor for Shiga toxin (Vero cytotoxin)-producing Escherichia coli O157 infection in humans. Emerg Infect Dis 2001; 7(6):1049-51.
(68) Locking ME, O'Brien SJ, Reilly WJ, et al. Risk factors for sporadic cases of Escherichia coli O157 infection: the importance of contact with animal excreta.
Epidemiol Infect 2001; 127(2):215-20.
(69) Michel P, Wilson JB, Martin SW, Clarke RC, McEwen SA, Gyles CL. Temporal and geographical distributions of reported cases of Escherichia coli O157:H7 infection in Ontario. Epidemiol Infect 1999; 122(2):193-200.
(70) Innocent GT, Mellor DJ, McEwen SA, et al. Spatial and temporal epidemiology of sporadic human cases of Escherichia coli O157 in Scotland, 1996-1999.
Epidemiol Infect 2005; 133(6):1033-41.
(71) Valcour JE, Michel P, McEwen SA, Wilson JB. Associations between indicators of livestock farming intensity and incidence of human Shiga toxin-producing Escherichia coli infection. Emerg Infect Dis 2002; 8(3):252-7.
(72) Parry SM, Salmon RL. Sporadic STEC O157 infection: secondary household transmission in Wales. Emerg Infect Dis 1998; 4(4):657-61.
(73) Seto EY, Soller JA, Colford JM, Jr. Strategies to reduce person-to-person transmission during widespread Escherichia coli O157:H7 outbreak.
Emerg Infect Dis 2007; 13(6):860-6.
(74) Tuttle J, Gomez T, Doyle MP, et al. Lessons from a large outbreak of Escherichia coli O157:H7 infections: insights into the infectious dose and method of widespread contamination of hamburger patties. Epidemiol Infect 1999; 122(2):185-92.
(75) Tilden J, Jr., Young W, McNamara AM, et al. A new route of transmission for Escherichia coli: infection from dry fermented salami.
Am J Public Health 1996; 86(8):1142-5.
(76) Willshaw GA, Thirlwell J, Jones AP, Parry S, Salmon RL, Hickey M. Vero cytotoxin-producing Escherichia coli O157 in beefburgers linked to an outbreak of diarrhoea, haemorrhagic colitis and haemolytic uraemic syndrome in Britain.
Lett Appl Microbiol 1994; 19(5):304-7.
(77) Cornick NA, Jelacic S, Ciol MA, Tarr PI. Escherichia coli O157:H7 infections:
discordance between filterable fecal shiga toxin and disease outcome.
J Infect Dis 2002; 186(1):57-63.
(78) Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL.
Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA 1993; 269(7):883-8.
(79) Al-Jader L, Salmon RL, Walker AM, Williams HM, Willshaw GA, Cheasty T. Outbreak of Escherichia coli O157 in a nursery: lessons for prevention.
Arch Dis Child 1999; 81(1):60-3.
(80) Carter AO, Borczyk AA, Carlson JA, et al. A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home.
N Engl J Med 1987; 317(24):1496-500.
(81) Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN. Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC
co-investigators. Epidemiol Infect 1993; 110(1):9-16.
(82) Rowe PC, Orrbine E, Ogborn M, et al. Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian inuit community:
intestinal illness in family members as a risk factor. J Pediatr 1994; 124(1):21-6.
(83) Task force on the Mass Outbreak of Diarrhea in School children of Sakai City. Report on the Outbreak of E.coli O157 infection in Sakai City. Sakai, Japan: Sakai City, 1997.
(84) Working Group of the former PHLS Advisory Committee on Gastrointestinal
Infections. Preventing person-to-person spread following gastrointestinal infections:
guidelines for public health physicians and environmental health officers.
Commun Dis Public Health 2004 Dec; 7(4):362-84.
(85) Keene WE. Lessons from investigations of foodborne disease outbreaks.
JAMA 1999; 281(19):1845-7.
(86) Neimann J, Engberg J, Molbak K, Wegener HC. A case-control study of risk factors for sporadic campylobacter infections in Denmark.
Epidemiol Infect 2003; 130(3):353-66.
(87) Bockemühl J. Karch H, Rüssmann, et al. Shiga-like Toxin (Verotoxin) -produzierende E. coli O22: H8-Übertragung durch unpasteurisierte Milch mit nachfolgender
(88) Karch H. Wiss R, Gloning H. et al. Hämolytisch-urämisches Syndrom bei Kleinkindern durch Verotoxin-produzierende Escherichia coli.
Dtsch Med Wochenschr 1990; 115: 489-95.
(89) Ammon A, Petersen LR, Karch H. A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H-.
J Infect Dis 1999; 179(5):1274-7.
(90) Mahon BE, Griffin PM, Mead PS, Tauxe RV. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli. Emerg Infect Dis 1997; 3(3):409-12.
(91) Robert Koch-Institut. SurvStat. 2010 (accessed: 1011.2010).
(92) Robert Koch-Institut. EHEC-Erkrankung. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2009. Mercedes-Druck, Berlin, 2010:67-70.
(93) Robert Koch-Institut. HUS (Hämolytisch-urämisches Syndrom), enteropathisch.
Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2009.
Mercedes-Druck, Berlin 2010:108-10.
(94) Werber D, Bielaszewska M, Frank C, Stark K, Karch H. Watch out for the even eviler cousin-sorbitol-fermenting E coli O157. Lancet 2011; 377(9762):298-9.
(95) Wadl M, Müller-Wiefel DE, Stark K, Fruth A, Werber D. Enteropathisches hämolytisch-urämisches Syndrom: Sporadischer Einzelfall oder Teil eines Krankheitsausbruchs? Monatsschrift Kinderheilkunde 2010; 159:152-60.
(96) Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM--South Australia 1995. MMWR Morb Mortal Wkly Rep 1995; 44(29):550-8.
(97) King LA, Mailles A, Mariani-Kurkdjian P, et al. Community-wide outbreak of Escherichia coli O157:H7 associated with consumption of frozen beef burgers.
Epidemiol Infect 2009; 137(6):889-96.
(98) Schimmer B, Eriksen HM, Nygard K, et al. An outbreak of haemolytic uraemic
syndrome associated with minced beef, Norway, January-February 2006: preliminary report. Euro Surveill 2006; 11(3):E060302.
(99) Friedrich AW, Bielaszewska M, Zhang WL, et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.
J Infect Dis 2002; 185(1):74-84.
(100) O'Brien AD, Tesh VL, Donohue-Rolfe A, et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol 1992; 180:65-94.
(101) Schmitt CK, McKee ML, O'Brien AD. Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511.
Infect Immun 1991; 59(3):1065-73.
(102) Pierard D, Muyldermans G, Moriau L, Stevens D, Lauwers S. Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol 1998; 36(11):3317-22.
(103) Weinstein DL, Jackson MP, Samuel JE, Holmes RK, O'Brien AD. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine. J Bacteriol 1988; 170(9):4223-30.
(104) Schmidt H, Scheef J, Morabito S, Caprioli A, Wieler LH, Karch H. A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons.
Appl Environ Microbiol 2000; 66(3):1205-8.
(105) Leung PH, Peiris JS, Ng WW, Robins-Browne RM, Bettelheim KA, Yam WC. A newly discovered verotoxin variant, VT2g, produced by bovine verocytotoxigenic
Escherichia coli. Appl Environ Microbiol 2003; 69(12):7549-53.
(106) Friedrich AW. Variabilität der Shigatoxine. Hyg Mikrobiol 2002; 6:99-103.
(107) Marques LRM, Peiris JSM, Crysz JSZ, et al. Escherichia coli strains isolated from pigs with edema disease produce a variant of Shiga-like toxin II.
FEMS Microbiol Lett 1987: 44:33-8.
(108) Muniesa M, Recktenwald J, Bielaszewska M, Karch H, Schmidt H. Characterization of a shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin. Infect Immun 2000; 68(9):4850-5.
(109) Bielaszewska M, Friedrich AW, Aldick T, Schurk-Bulgrin R, Karch H. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 2006; 43(9):1160-7.
(110) Karch H, Mellmann A, Bielaszewska M. Epidemiology and pathogenesis of enterohaemorrhagic Escherichia coil.
Berl Munch Tierarztl Wochenschr 2009; 122(11-12):417-24.
(111) McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.
Proc Natl Acad Sci U S A 1995; 92(5):1664-8.
(112) Beutin L, Montenegro MA, Orskov I, et al. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli.
J Clin Microbiol 1989; 27(11):2559-64.
(113) Schmidt H, Karch H, Beutin L. The large-sized plasmids of enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are presumably members of the E. coli alpha-hemolysin family. FEMS Microbiol Lett 1994; 117(2):189-96.
(114) Brunder W, Schmidt H, Karch H. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V.
Mol Microbiol 1997; 24(4):767-78.
(115) Orth D, Ehrlenbach S, Brockmeyer J, et al. EspP, a serine protease of
enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5. Infect Immun 2010; 78(10):4294-301.
(116) Brunder W, Schmidt H, Karch H. KatP, a novel catalase-peroxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7.
Microbiology 1996; 142:3305-15.
(117) Karch H. The role of virulence factors in enterohemorrhagic Escherichia coli
(118) Beutin L, Geier D, Zimmermann S, Karch H. Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species. J Clin Microbiol 1995; 33(3):631-5.
(119) Willshaw GA, Scotland SM, Smith HR, Rowe B. Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157.
J Infect Dis 1992; 166(4):797-802.
(120) Gyles CL. VT toxemia in animal models. In: Karmali MA, Goglio A G, eds. Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science B.V., Amsterdam, The Netherlands. 1994:223-40.
(121) Louise CB, Obrig TG. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 1995; 172(5):1397-401.
(122) Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.
JAMA 1989; 262(3):355-9.
(123) Schmidt H, Karch H. Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol 1996; 34(10):2364-7.
(124) Sandhu KS, Clarke RC, Gyles CL. Hemolysin phenotypes and genotypes of eaeA-positive and eaeA-negative bovine verotoxigenic Escherichia coli.
Adv Exp Med Biol 1997; 412:295-302.
(125) Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL.
Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 1999; 37(3):497-503.
(126) Friedrich AW, Bielaszewska M, Zhang WL, et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.
J Infect Dis 2002; 185(1):74-84.
(127) Tamplin ML. Inactivation of Escherichia coli O157:H7 in simulated human gastric fluid. Appl Environ Microbiol 2005; 71(1):320-5.
(128) Orth D, Khan AB, Naim A, et al. Shiga toxin activates complement and binds factor H:
evidence for an active role of complement in hemolytic uremic syndrome.
J Immunol 2009; 182(10):6394-400.
(129) Thurman JM, Marians R, Emlen W, et al. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.
Clin J Am Soc Nephrol 2009; 4(12):1920-4.
(130) Werber D, Behnke SC, Fruth A, et al. Shiga Toxin-producing Escherichia coli Infection in Germany--Different Risk Factors for Different Age Groups.
Am J Epidemiol 2007; 165(4):425-34.
(131) Kassenborg HD, Hedberg CW, Hoekstra M, et al. Farm visits and undercooked hamburgers as major risk factors for sporadic Escherichia coli O157:H7 infection:
data from a case-control study in 5 FoodNet sites.
Clin Infect Dis 2004; 38 Suppl 3:S271-S278.
(132) Voetsch AC, Kennedy MH, Keene WE, et al. Risk factors for sporadic Shiga toxin-producing Escherichia coli O157 infections in FoodNet sites, 1999-2000.
Epidemiol Infect 2007; 135(6):993-1000.
(133) Parry SM, Salmon RL, Willshaw GA, Cheasty T. Risk factors for and prevention of sporadic infections with vero cytotoxin (shiga toxin) producing Escherichia coli O157.
Lancet 1998; 351(9108):1019-22.
(134) Frank C, Kapfhammer S, Werber D, Stark K, Held L. Cattle density and Shiga toxin-producing Escherichia coli infection in Germany: increased risk for most but not all serogroups. Vector Borne Zoonotic Dis 2008; 8(5):635-43.
(135) Bell BP, Goldoft M, Griffin PM, et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 1994; 272(17):1349-53.
(136) Ake JA, Jelacic S, Ciol MA, et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Pediatrics 2005; 115(6):e673-e680.
(137) Health Protection Scotland. Guidance for the Public Health Management of Infection with Verotoxigenic Escherichia coli (VTEC). 2008; available at:
http://www.documents.hps.scot.nhs.uk/about-hps/hpn/vtec.pdf (accessed: 12.11.10).
(138) Doorduyn Y, Van Den Brandhof WE, Van Duynhoven YT, Wannet WJ, Van PW. Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104)
infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiol Infect 2006; 134(3):617-26.
(139) Bülte MHSSP. Enterohämorrhagische E.coli (EHEC) - aktuelle
Lebensmittelinfektionserreger auch in der Bundesrepublik Deutschland.
Fleischwirtschaft 1996; 76:88-91.
(140) Werber D, Beutin L, Pichner R, Stark K, Fruth A. Shiga toxin-producing Escherichia coli serogroups in food and patients, Germany.
Emerg Infect Dis 2008; 14(11):1803-6.
(141) Werber D, Fruth A, Liesegang A, et al. A multistate outbreak of Shiga toxin-producing Escherichia coli O26:H11 infections in Germany, detected by molecular subtyping surveillance. J Infect Dis 2002; 186(3):419-22.
(142) Tokars JI, Burkom H, Xing J, et al. Enhancing time-series detection algorithms for automated biosurveillance. Emerg Infect Dis 2009; 15(4):533-9.
(143) Werber D, Kramer MH, Buchholz U, et al. [Surveillance of infectious foodborne diseases after enactment of the German Protection against Infection Act in 2001.
Potentials and requirements]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2006; 49(10):1020-6.
(144) Reingold AL. Outbreak investigations--a perspective.
Emerg Infect Dis 1998; 4(1):21-7.
(145) Boxrud D, Monson T, Stiles T, Besser J. The role, challenges, and support of pulsenet laboratories in detecting foodborne disease outbreaks.
Public Health Rep 2010; 125 Suppl 2:57-62.
(146) Swaminathan B, Barrett TJ, Hunter SB, Tauxe RV. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States.
Emerg Infect Dis 2001; 7(3):382-9.
(147) Elbasha EH, Fitzsimmons TD, Meltzer MI. Costs and benefits of a subtype-specific surveillance system for identifying Escherichia coli O157:H7 outbreaks.
Emerg Infect Dis 2000; 6(3):293-7.
(148) Swaminathan B, Gerner-Smidt P, Ng LK, et al. Building PulseNet International: an interconnected system of laboratory networks to facilitate timely public health recognition and response to foodborne disease outbreaks and emerging foodborne diseases. Foodborne Pathog Dis 2006; 3(1):36-50.
(149) Beutin L. Emerging enterohaemorrhagic Escherichia coli, causes and effects of the rise of a human pathogen. J Vet Med B Infect Dis Vet Public Health 2006; 53(7):299-305.
(150) Manning SD, Motiwala AS, Springman AC, et al. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks.
Proc Natl Acad Sci U S A 2008; 105(12):4868-73.
(151) Nielsen EM, Scheutz F. Characterisation of Escherichia coli O157 isolates from Danish cattle and human patients by genotyping and presence and variants of virulence genes. Vet Microbiol 2002; 88(3):259-73.
(152) Pradel N, Ye C, Livrelli V, Xu J, Joly B, Wu LF. Contribution of the twin arginine translocation system to the virulence of enterohemorrhagic Escherichia coli O157:H7.
Infect Immun 2003; 71(9):4908-16.
(153) Werber D, Fruth A, Buchholz U, et al. Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome. Eur J Clin Microbiol Infect Dis 2003; 22(12):726-30.
(154) Beutin L, Jahn S, Fach P. Evaluation of the 'GeneDisc' real-time PCR system for detection of enterohaemorrhagic Escherichia coli (EHEC) O26, O103, O111, O145 and O157 strains according to their virulence markers and their O- and H-antigen-associated genes. J Appl Microbiol 2009; 106(4):1122-32.